Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015 (2015), Article ID 143145, 7 pages
http://dx.doi.org/10.1155/2015/143145
Review Article

Cardiovascular Disease, Mitochondria, and Traditional Chinese Medicine

1Department of Cardiology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China
2Clinical Medical College, Hubei University of Chinese Medicine, Wuhan 430065, China

Received 22 May 2014; Revised 6 September 2014; Accepted 14 September 2014

Academic Editor: Keji Chen

Copyright © 2015 Jie Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. C. Wallace, “A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine,” Annual Review of Genetics, vol. 39, pp. 359–407, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. D. C. Wallace, “Mitochondrial genetics: a paradigm for aging and degenerative diseases?” Science, vol. 256, no. 5057, pp. 628–632, 1992. View at Publisher · View at Google Scholar · View at Scopus
  3. D. M. Krzywanski, D. R. Moellering, J. L. Fetterman, K. J. Dunham-Snary, M. J. Sammy, and S. W. Ballinger, “The mitochondrial paradigm for cardiovascular disease susceptibility and cellular function: a complementary concept to Mendelian genetics,” Laboratory Investigation, vol. 91, no. 8, pp. 1122–1135, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Dromparis and E. D. Michelakis, “Mitochondria in vascular health and disease,” Annual Review of Physiology, vol. 75, pp. 95–126, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. D. C. Wallace, “Mitochondria as chi,” Genetics, vol. 179, no. 2, pp. 727–735, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Tomikura, I. Hisatome, M. Tsuboi et al., “Coordinate induction of AMP deaminase in human atrium with mitochondrial DNA deletion,” Biochemical and Biophysical Research Communications, vol. 302, no. 2, pp. 372–376, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Marín-García and M. J Goldenthal, “The mitochondrial organelle and the heart,” Revista Española de Cardiología, vol. 55, no. 12, pp. 1293–1310, 2002. View at Google Scholar
  8. N. Robinson, “Integrative medicine: traditional Chinese medicine, a model?” Chinese Journal of Integrative Medicine, vol. 17, no. 1, pp. 21–25, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. H. R. Schumacher, “West meets East—observations on integrative medicine in rheumatology from the USA,” Chinese Journal of Integrative Medicine, vol. 14, no. 3, pp. 165–166, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Grace and J. Higgs, “Integrative medicine: enhancing quality in primary health care,” Journal of Alternative and Complementary Medicine, vol. 16, no. 9, pp. 945–950, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. H. S. Boon and N. Kachan, “Integrative medicine: a tale of two clinics,” BMC Complementary and Alternative Medicine, vol. 8, no. 1, article 32, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Botto, S. Berti, S. Manfredi et al., “Detection of mtDNA with 4977 bp deletion in blood cells and atherosclerotic lesions of patients with coronary artery disease,” Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 570, no. 1, pp. 81–88, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Sabatino, N. Botto, A. Borghini, S. Turchi, and M. G. Andreassi, “Development of a new multiplex quantitative real-time PCR assay for the detection of the mtDNA4977 deletion in coronary artery disease patients: a link with telomere shortening,” Environmental and Molecular Mutagenesis, vol. 54, no. 5, pp. 299–307, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Y. Polisecki, L. E. Schreier, J. Ravioli, and D. Corach, “Common mitochondrial DNA deletion associated with sudden natural death in adults,” Journal of Forensic Sciences, vol. 49, no. 6, pp. 1335–1338, 2004. View at Google Scholar · View at Scopus
  15. C. Harrison-Gómez, A. Harrison-Ragle, A. Macías-Hernández, and V. Guerrero-Sánchez, “A3243G mitochondrial DNA mutation and heterogeneous phenotypic expression,” Revista Médica del Instituto Mexicano del Seguro Social, vol. 47, no. 2, pp. 219–225, 2009. View at Google Scholar · View at Scopus
  16. K. Majamaa-Voltti, K. Majamaa, K. Peuhkurinen, T. H. Mäkikallio, and H. V. Huikuri, “Cardiovascular autonomic regulation in patients with 3243A>G mitochondrial DNA mutation,” Annals of Medicine, vol. 36, no. 3, pp. 225–231, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. K. K. Abu-Amero, O. M. Al-Boudari, A. Mousa et al., “The mitochondrial DNA variant 16189T>C is associated with coronary artery disease and myocardial infarction in Saudi Arabs,” Genetic Testing and Molecular Biomarkers, vol. 14, no. 1, pp. 43–47, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Ding, B. Xia, J. Yu, J. Leng, and J. Huang, “Mitochondrial DNA mutations and essential hypertension (Review),” International Journal of Molecular Medicine, vol. 32, no. 4, pp. 768–774, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Schwartz, A. Duka, F. Sun, J. Cui, A. Manolis, and H. Gavras, “Mitochondrial genome mutations in hypertensive individuals,” The American Journal of Hypertension, vol. 17, no. 7, pp. 629–635, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. Q. Yang, S. K. Kim, F. Sun et al., “Maternal influence on blood pressure suggests involvement of mitochondrial DNA in the pathogenesis of hypertension: the Framingham Heart Study,” Journal of Hypertension, vol. 25, no. 10, pp. 2067–2073, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Liu, R. Li, Z. Li et al., “Mitochondrial transfer RNA met 4435a>g mutation is associated with maternally inherited hypertension in a chinese pedigree,” Hypertension, vol. 53, no. 6, pp. 1083–1090, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Liu, Q. Yang, S.-J. Hwang et al., “Association of genetic variation in the mitochondrial genome with blood pressure and metabolic traits,” Hypertension, vol. 60, no. 4, pp. 949–956, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Guo, X.-Y. Zhuang, A.-M. Zhang et al., “Presence of mutation m.14484T > C in a Chinese family with maternally inherited essential hypertension but no expression of LHON,” Biochimica et Biophysica Acta: Molecular Basis of Disease, vol. 1822, no. 10, pp. 1535–1543, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. E. Arbustini, M. Diegoli, R. Fasani et al., “Mitochondrial DNA mutations and mitochondrial abnormalities in dilated cardiomyopathy,” The American Journal of Pathology, vol. 153, no. 5, pp. 1501–1510, 1998. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Y. Li, D. Chen, S. C. Watkins, and A. M. Feldman, “Mitochondrial abnormalities in tumor necrosis factor-α-induced heart failure are associated with impaired DNA repair activity,” Circulation, vol. 104, no. 20, pp. 2492–2497, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. M. M. S. G. Cardena, A. J. Mansur, A. D. C. Pereira, and C. Fridman, “A new duplication in the mitochondrially encoded tRNA proline gene in a patient with dilated cardiomyopathy,” Mitochondrial DNA, vol. 24, no. 1, pp. 46–49, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. W. S. Shin, M. Tanaka, J.-I. Suzuki, C. Hemmi, and T. Toyo-oka, “A novel homoplasmic mutation in mtDNA with a single evolutionary origin as a risk factor for cardiomyopathy,” The American Journal of Human Genetics, vol. 67, no. 6, pp. 1617–1620, 2000. View at Google Scholar
  28. J. J. Liu and X. M. Wang, The Medicine and Health of Mitochondria, vol. 129, Science Press, Beijing, China, 2012.
  29. S. Liu, Y. Bai, J. Huang et al., “Do mitochondria contribute to left ventricular non-compaction cardiomyopathy? New findings from myocardium of patients with left ventricular non-compaction cardiomyopathy,” Molecular Genetics and Metabolism, vol. 109, no. 1, pp. 100–106, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. E. Arbustini, R. Fasani, P. Morbini et al., “Coexistence of mitochondrial DNA and β myosin heavy chain mutations in hypertrophic cardiomyopathy with late congestive heart failure,” Heart, vol. 80, no. 6, pp. 548–558, 1998. View at Google Scholar · View at Scopus
  31. F. M. Santorelli, A. Tessa, G. D'amati, and C. Casali, “The emerging concept of mitochondrial cardiomyopathies,” American Heart Journal, vol. 141, no. 1, pp. 5A–12A, 2001. View at Google Scholar · View at Scopus
  32. T. Ide, H. Tsutsui, S. Hayashidani et al., “Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction,” Circulation Research, vol. 88, no. 5, pp. 529–535, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Kinugawa and H. Tsutsui, “Oxidative stress and heart failure,” Nippon Rinsho. Japanese Journal of Clinical Medicine, vol. 64, no. 5, pp. 848–853, 2006. View at Google Scholar · View at Scopus
  34. H. Tsutsui, T. Ide, and S. Kinugawa, “Mitochondrial oxidative stress, DNA damage, and heart failure,” Antioxidants and Redox Signaling, vol. 8, no. 9-10, pp. 1737–1744, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. H. Tsutsui, S. Kinugawa, and S. Matsushima, “Oxidative stress and heart failure,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 301, no. 6, pp. H2181–H2190, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. H. Tsutsui, S. Kinugawa, and S. Matsushima, “Oxidative stress and mitochondrial DNA damage in heart failure,” Circulation Journal, vol. 72, pp. A31–A37, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Ikeuchi, H. Matsusaka, D. Kang et al., “Overexpression of mitochondrial transcription factor A ameliorates mitochondrial deficiencies and cardiac failure after myocardial infarction,” Circulation, vol. 112, no. 5, pp. 683–690, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Fujino, T. Ide, M. Yoshida et al., “Recombinant mitochondrial transcription factor A protein inhibits nuclear factor of activated T cells signaling and attenuates pathological hypertrophy of cardiac myocytes,” Mitochondrion, vol. 12, no. 4, pp. 449–458, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. N. Suematsu, H. Tsutsui, J. Wen et al., “Oxidative stress mediates tumor necrosis factor-α-induced mitochondrial DNA damage and dysfunction in cardiac myocytes,” Circulation, vol. 107, no. 10, pp. 1418–1423, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. I. A. Sobenin, D. A. Chistiakov, Y. V. Bobryshev, A. Y. Postnov, and A. N. Orekhov, “Mitochondrial mutations in atherosclerosis: new solutions in research and possible clinical applications,” Current Pharmaceutical Design, vol. 19, no. 33, pp. 5942–5953, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. D. Harman, “Aging: a theory based on free radical and radiation chemistry,” The Journal of Gerontology, vol. 11, no. 3, pp. 298–300, 1956. View at Publisher · View at Google Scholar · View at Scopus
  42. S. W. Ballinger, C. Patterson, C. A. Knight-Lozano et al., “Mitochondrial integrity and function in atherogenesis,” Circulation, vol. 106, no. 5, pp. 544–549, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. E. P. Yu and M. R. Bennett, “Mitochondrial DNA damage and atherosclerosis,” Trends in Endocrinology and Metabolism, vol. 25, no. 9, pp. 481–487, 2014. View at Google Scholar
  44. E. Yu, P. A. Calvert, J. R. Mercer et al., “Mitochondrial DNA damage can promote atherosclerosis independently of reactive oxygen species through effects on smooth muscle cells and monocytes and correlates with higher-risk plaques in humans,” Circulation, vol. 128, no. 7, pp. 702–712, 2013. View at Google Scholar
  45. X. J. Xiong, F. Borrelli, A. S. Ferreira, T. Ashfaq, and B. Feng, “Herbal medicines for cardiovascular diseases,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 809741, 2014. View at Publisher · View at Google Scholar
  46. X. J. Xiong, X. C. Yang, Y. M. Liu, Y. Zhang, P. Q. Wang, and J. Wang, “Chinese herbal formulas for treating hypertension in traditional Chinese medicine: perspective of modern science,” Hypertension Research, vol. 36, pp. 570–579, 2013. View at Google Scholar
  47. J. Wang and X. J. Xiong, “Current situation and perspectives of clinical study in integrative medicine in China,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 268542, 11 pages, 2012. View at Publisher · View at Google Scholar
  48. F. Lin, J. Wang, L. L. Guo, and Q. Y. He, “Composition law of proprietary Chinese medicine for coronary heart disease in Chinese pharmacopoeia,” Journal of Traditional Chinese Medicine, vol. 54, no. 18, pp. 1596–1599, 2013. View at Google Scholar
  49. Y. Yu, S. Wang, B. Nie, Y. Sun, Y. Yan, and L. Zhu, “Effect of Astragali Radix injection on myocardial cell mitochondrial structure and function in process of reversing myocardial cell hypertrophy,” Zhongguo Zhong Yao Za Zhi, vol. 37, no. 7, pp. 979–984, 2012. View at Google Scholar
  50. H. Y. Leung, P. Y. Chiu, M. K. T. Poon, and K. M. Ko, “A Yang-invigorating Chinese herbal formula enhances mitochondrial functional ability and antioxidant capacity in various tissues of male and female rats,” Rejuvenation Research, vol. 8, no. 4, pp. 238–247, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. K. M. Ko, T. Y. Y. Leon, D. H. F. Mak, P. Y. Chiu, Y. Du, and M. K. Poon, “A characteristic pharmacological action of “Yang-invigorating” Chinese tonifying herbs: enhancement of myocardial ATP-generation capacity,” Phytomedicine, vol. 13, no. 9, pp. 636–642, 2006. View at Google Scholar
  52. A. H.-L. Siu and K. M. Ko, “Herba Cistanche extract enhances mitochondrial glutathione status and respiration in rat hearts, with possible induction of uncoupling proteins,” Pharmaceutical Biology, vol. 48, no. 5, pp. 512–517, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. N. P. Sudheesh, T. A. Ajith, and K. K. Janardhanan, “Ganoderma lucidum (Fr.) P. Karst enhances activities of heart mitochondrial enzymes and respiratory chain complexes in the aged rat,” Biogerontology, vol. 10, no. 5, pp. 627–636, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. M. Zhao, W. Wu, X. Duan et al., “The protective effects of sini decoction on mitochondrial function in adriamycin-induced heart failure rats,” Zhong Yao Cai, vol. 28, no. 6, pp. 486–489, 2005. View at Google Scholar · View at Scopus
  55. Y. Zhang, H.-M. Sun, X. He et al., “Da-Bu-Yin-Wan and Qian-Zheng-San, two traditional Chinese herbal formulas, up-regulate the expression of mitochondrial subunit NADH dehydrogenase 1 synergistically in the mice model of Parkinson's disease,” Journal of Ethnopharmacology, vol. 146, no. 1, pp. 363–371, 2013. View at Publisher · View at Google Scholar · View at Scopus
  56. H.-W. Zhao, F. Qin, Y.-X. Liu, X. Huang, and P. Ren, “Antiapoptotic mechanisms of Chinese medicine formula, Guan-Xin-Er-Hao, in the rat ischemic heart,” Tohoku Journal of Experimental Medicine, vol. 216, no. 4, pp. 309–316, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. J. V. Smith, A. J. Burdick, P. Golik, I. Khan, D. Wallace, and Y. Luo, “Anti-apoptotic properties of Ginkgo biloba extract EGb 761 in differentiated PC12 cells,” Cellular and Molecular Biology, vol. 48, no. 6, pp. 699–707, 2002. View at Google Scholar · View at Scopus
  58. P. Y. Chiu, H. Y. Leung, P. K. Leong et al., “Danshen-Gegen decoction protects against hypoxia/reoxygenation-induced apoptosis by inhibiting mitochondrial permeability transition via the redox-sensitive ERK/Nrf2 and PKCε/mK ATP pathways in H9c2 cardiomyocytes,” Phytomedicine, vol. 19, no. 2, pp. 99–110, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. B. K. Wagner, T. Kitami, T. J. Gilbert et al., “Large-scale chemical dissection of mitochondrial function,” Nature Biotechnology, vol. 26, no. 3, pp. 343–351, 2008. View at Publisher · View at Google Scholar · View at Scopus